NASDAQ: RGC
Regencell Bioscience Holdings Limited
Healthcare · Drug Manufacturers - Specialty & Generic
Market Cap
$10.35B
52w High
$83.60
52w Low
$9.39
P/E
-1,468.68
Volume
27.10K
Outstanding Shares
494.49M
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 33.66% over the last year. Free cash flow grew 100% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum. The operating data is doing enough work that the move does not need an overvaluation story to explain it.
What would invalidate this read
If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company.
Valuation
Stock splits
Every 1 shares became 38
Profitability & growth
Analyst consensus
0
Buy
4
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jun 5, 2026
Q1 FY26 · EPS est — · Revenue est —
View